Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
ENPICOM partners with Erasmus University Medical Center in effort to advance research of nanobodies against cancer
, /in E-News /by panglobalENPICOM, a bioinformatics software solutions provider, will collaborate with Erasmus Medical Center, Rotterdam, to identify and develop nanobodies against cancer by utilizing ENPICOM’s immune repertoire data analysis services and software solutions.
CN Bio appoints Joseph Parisi as US Director of Sales to support growing demand for OOC systems
, /in E-News /by panglobalCN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single- and multi-organ microphysiological systems (MPS), has appointed Joseph Parisi as US Director of Sales. In his new role, Parisi will lead the expansion of the company’s sales and support activities for the US market to address the growing demand for new alternative methodologies […]
Pluri launches cell therapy CDMO
, /in E-News /by panglobalThe biotech company Pluri has launched a new business division offering cell therapy manufacturing services as a Contract Development and Manufacturing Organization (CDMO): PluriCDMO.
CLSI introduces Country- Based Pricing to increase global access to laboratory standards
, /in E-News /by panglobalThe Clinical and Laboratory Standards Institute (CLSI) has implemented new Country-Based Pricing
Vetter becomes member of the German Association of Research-Based Pharmaceutical Companies
, /in E-News /by panglobalVetter, a globally operating contract development and manufacturing organization (CDMO), has joined the German Association of Research-Based Pharmaceutical Companies (vfa) as an associate member. With this membership, the vfa recognizes the significant role that the pharmaceutical service provider plays in the field of complex injectable drugs.
Biointelect and CR2O forge strategic partnership to provide advanced end-to-end commercialisation solutions for the life-science sector
, /in E-News /by panglobalAustralian, European and U.S. clients are now able to tap into world-class strategic advice and full-service clinical trial capabilities following the announcement of Biointelect’s and CR2O’s new strategic partnership.
Capricorn Scientific and ExcellGene form strategic partnership to support biotech industries
, /in E-News /by panglobalCapricorn Scientific and ExcellGene have established a strategic partnership within the biotechnology sector. Applying their collective expertise and capabilities, the collaboration seeks to help customers by optimizing processes, developing products, and offering solutions in biotechnology. The partnership is dedicated to customeroriented solutions and a commitment to excellence, with the aim of advancing biotech research, development, […]
PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Disease
, /in E-News /by panglobalPharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease (AD) and other neurodegenerative diseases, will collaborate with Sheffield Hallam University in the field of epigenetics. The partnership will focus on ‘gene-based environmental biomarkers’ – epigenetic markers – for calculating risk scores for Alzheimer’s diseases. Together with PharmaKure’s blood-based biomarker, ALZmetrix https://bitly.ws/3eZTQ, this […]
Johnson & Johnson to acquire Ambrx to advance nextgen antibody drug conjugates for cancer treatment
, /in E-News /by panglobalJohnson & Johnson has entered into a definitive agreement to acquire Ambrx Biopharma, a clinical-stage biopharmaceutical company with a proprietary synthetic biology technology platform to design and develop next-generation antibody drug conjugates (ADCs), in an all-cash merger transaction for a total equity value of approximately $2 billion, or $1.9 billion net of estimated cash acquired.
Biomarkers in heart failure | Beyond laboratory values
, /in Cardiac Biomarkers, Featured Articles /by panglobalby Dr Roopa Rao and Arden Shen The incidence of heart failure (HF) is increasing globally. Biomarkers in HF play a key role in diagnosis and prognostication. Ideal biomarkers should be easily measurable with distinct values in normal physiology, disease state and be a marker of therapeutic intervention. Several biomarkers have emerged that are potentially […]